Literature DB >> 26348487

Drug use disorders in the polydrug context: new epidemiological evidence from a foodborne outbreak approach.

Catalina Lopez-Quintero1, James C Anthony1.   

Abstract

As epidemiologists studying foodborne illness outbreaks, we do not ask luncheon attendees to say which food caused their illnesses. Instead, we use measurement and analysis methods to estimate food-specific risk variations. Here, we adapt the foodborne outbreak approach to develop new estimates of drug use disorder risk for single-drug and polydrug users, without attributing the syndrome to a specific drug when multiple drugs have been used. We estimate drug use disorder risk for cannabis-only users as a reference value. We then derive comparative relative risk estimates for users of other drug subtypes, including polydrug combinations. Data are from the 2002 to 2003 U.S. National Comorbidity Survey Replication, a nationally representative sample of household residents (18+ years), with standardized drug use and drug dependence assessments. Multiple logistic regression provides odds ratio estimates of relative risk. With this approach, for every 1000 cannabis-only users, an estimated 17 had become cases (1.7%). By comparison, polydrug users and cocaine-only users had much greater cumulative incidence (>10%), even with adjustment for covariates and local area matching (P < 0.001). Using this approach, we find exceptionally low risk for cannabis-only users and greater risk for polydrug and cocaine-only users.
© 2015 New York Academy of Sciences.

Entities:  

Keywords:  alcohol; conduct problems; drug addiction; drug dependence; drug use disorders; epidemiology; multiple drug use; polydrug; tobacco

Mesh:

Year:  2015        PMID: 26348487      PMCID: PMC4785025          DOI: 10.1111/nyas.12868

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

1.  Polydrug abuse and the maturing national drug abuse data base.

Authors:  R L DuPont
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

2.  Risk of becoming cocaine dependent: epidemiological estimates for the United States, 2000-2001.

Authors:  Megan S O'Brien; James C Anthony
Journal:  Neuropsychopharmacology       Date:  2005-05       Impact factor: 7.853

3.  Epidemiological patterns of extra-medical drug use in the United States: evidence from the National Comorbidity Survey Replication, 2001-2003.

Authors:  Louisa Degenhardt; Wai Tat Chiu; Nancy Sampson; Ronald C Kessler; James C Anthony
Journal:  Drug Alcohol Depend       Date:  2007-05-03       Impact factor: 4.492

4.  Concurrent and simultaneous use of alcohol with cocaine: results of national survey.

Authors:  B F Grant; T C Harford
Journal:  Drug Alcohol Depend       Date:  1990-02       Impact factor: 4.492

5.  Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys.

Authors:  Josep Maria Haro; Saena Arbabzadeh-Bouchez; Traolach S Brugha; Giovanni de Girolamo; Margaret E Guyer; Robert Jin; Jean Pierre Lepine; Fausto Mazzi; Blanca Reneses; Gemma Vilagut; Nancy A Sampson; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

6.  Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore.

Authors:  J C Anthony; M Folstein; A J Romanoski; M R Von Korff; G R Nestadt; R Chahal; A Merchant; C H Brown; S Shapiro; M Kramer
Journal:  Arch Gen Psychiatry       Date:  1985-07

7.  The National Comorbidity Survey Replication (NCS-R): background and aims.

Authors:  Ronald C Kessler; Kathleen R Merikangas
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

8.  Improving targets for the prevention of drug use disorders: sociodemographic predictors of transitions across drug use stages in the national comorbidity survey replication.

Authors:  Joel Swendsen; James C Anthony; Kevin P Conway; Louisa Degenhardt; Lisa Dierker; Meyer Glantz; Jianping He; Amanda Kalaydjian; Ronald C Kessler; Nancy Sampson; Kathleen R Merikangas
Journal:  Prev Med       Date:  2008-09-26       Impact factor: 4.018

9.  The natural course of cannabis use, abuse and dependence during the first decades of life.

Authors:  Axel Perkonigg; Renee D Goodwin; Agnes Fiedler; Silke Behrendt; Katja Beesdo; Roselind Lieb; Hans-Ulrich Wittchen
Journal:  Addiction       Date:  2008-03       Impact factor: 6.526

Review 10.  Epidemiologic analysis of alcohol and tobacco use.

Authors:  J C Anthony; F Echeagaray-Wagner
Journal:  Alcohol Res Health       Date:  2000
View more
  5 in total

1.  Developmental pathways of adolescent cannabis use: Risk factors, outcomes and sex-specific differences.

Authors:  Samuel W Hawes; Elisa M Trucco; Jacqueline C Duperrouzel; Stefany Coxe; Raul Gonzalez
Journal:  Subst Use Misuse       Date:  2018-11-05       Impact factor: 2.164

2.  Transitioning from First Drug Use to Dependence Onset: Illustration of a Multiparametric Approach for Comparative Epidemiology.

Authors:  Olga A Vsevolozhskaya; James C Anthony
Journal:  Neuropsychopharmacology       Date:  2015-07-15       Impact factor: 7.853

Review 3.  Cannabis Epidemiology: A Selective Review.

Authors:  James C Anthony; Catalina Lopez-Quintero; Omayma Alshaarawy
Journal:  Curr Pharm Des       Date:  2017-01-04       Impact factor: 3.116

4.  Polysubstance use among frequent marijuana users: an examination of John Henryism Active Coping, psychiatric symptoms, and family social support among African American incarcerated men.

Authors:  Paris B Wheeler; Danelle Stevens-Watkins; Jardin N Dogan; Daniel McCarthy
Journal:  J Ethn Subst Abuse       Date:  2020-07-22       Impact factor: 1.331

5.  Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis.

Authors:  Eduardo R Butelman; Angelo G I Maremmani; Silvia Bacciardi; Carina Y Chen; Joel Correa da Rosa; Mary Jeanne Kreek
Journal:  Front Psychiatry       Date:  2018-06-27       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.